TITLE

Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma

AUTHOR(S)
Rajakulasingam, K; Polosa, R; Church, M K; Howarth, P H; Holgate, S T
PUB. DATE
May 1994
SOURCE
Thorax;May1994, Vol. 49 Issue 5, p485
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66040561

 

Related Articles

  • Some Aspects on Comparative Efficacy Studies with Inhaled Corticosteroids in Asthma. Selroos, Olof // Current Drug Therapy;Jan2007, Vol. 2 Issue 1, p57 

    This review evaluates dose-response and comparative studies with inhaled corticosteroids (ICS) in asthma. A dose--response relationship for lung function variables has been demonstrated for some ICS, but not for all. Measurements of anti-inflammatory properties, e.g. bronchial challenge with...

  • Respiratory allergy and asthma.  // Current Medical Literature: Allergy;2003, Vol. 11 Issue 1, p8 

    Presents citations and clinicians' notes about respiratory allergy and asthma. 'Airways hyper-responsiveness to bradykinin and methacholine: Effects of inhaled fluticasone,' by C.J. Reynolds, A. Togias et al.; 'Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract...

  • Malabsorption of frusemide caused by phenytoin. Fine, Adrian; Henderson, I.S.; Morgan, D.R.; Tilstone, W.J. // British Medical Journal;10/22/1977, Vol. 2 Issue 6094, p1061 

    Examines the malabsorption of frusemide caused by phenytoin. Effect of phenytoin on the absorption of frusemide; Renal response to frusemide; Mechanism of the malabsorption.

  • Furosemide Protective Effect Against Airway Obstruction. Cavaliere, Franco; Masieri, Simonetta // Current Drug Targets;Jun2002, Vol. 3 Issue 3, p197 

    Furosemide (frusemide) is mainly employed as a powerful diuretic that inhibits Na and K reabsorption in renal tubules. However other valuable pharmacological effects have been discovered that include a protective action from bronchospasm. The effects of furosemide on airways have been recognized...

  • Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers, René; Boorsma, Martin; van der Woude, Hanneke J.; Jonkers, René E. // Respiratory Research;2010, Vol. 11, p66 

    Background: The budesonide/formoterol combination is successfully used for fast relief of asthma symptoms in addition to its use as maintenance therapy. The temporarily increased corticosteroid dose during increasing inhaler use for symptom relief is likely to suppress any temporary increase in...

  • RoIe of cysteinyl leukotrienes in adenosine 5' -monophosphate induced bronchoconstriction in asthma. Rorke, S.; Jennison, S.; Jeffs, J. A.; Sampson, A. P.; Arshad, H.; Holgate, S. T. // Thorax;Apr2002, Vol. 57 Issue 4, p323 

    Background: Adenosine induced bronchoconstriction in patients with asthma is thought to be mediated by the synthesis and release of autacoids from airway mast cells. In vitro, adenosine induced constriction of asthmatic bronchi is blocked by a combination of specific histamine and cysteinyl...

  • Adenosine and Adenosine Receptors in the Pathomechanism and Treatment of Respiratory Diseases. Vass, G.; Horváth, I. // Current Medicinal Chemistry;2008, Vol. 15 Issue 9, p917 

    It has been known for a long time that inhaled adenosine-monophosphate (AMP) induces airway obstruction in asthmatic patients, but not in healthy subjects. The mechanism of AMP is indirect and occurs via its decay product, adenosine. It stimulates mast cells through its low-affinity receptor A2B...

  • salmeterol.  // Davis's Drug Guide for Nurses, 10th edition;2007, p1058 

    This article presents a nurse's guide to the bronchodilator salmeterol. The indications of salmeterol are for the long-term control of reversible airway obstruction due to asthma and for maintenance treatment of asthma and prevention of bronchospasm. Salmeterol works by producing accumulation of...

  • Inhaled atrial natriuretic peptide and asthmatic airways. Hulks, Geoffrey; Thomson, Neil C. // BMJ: British Medical Journal (International Edition);5/2/92, Vol. 304 Issue 6835, p1156 

    Examines the bronchoprotective effect of inhaled atrial natriuretic peptide. Protection in the hyperreactive airway during inhalation; Use of autoradiography; Bronchodilator treatment for asthma.

  • Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Gauvreau, Gail M.; Boulet, Louis-Philippe; Schmid-Wirlitsch, Christine; Côté, Johanne; Duong, MyLinh; Killian, Kieran J.; Milot, Joanne; Deschesnes, Francine; Strinich, Tara; Watson, Richard M.; Bredenbröker, Dirk; O'Byrne, Paul M. // Respiratory Research;Oct2011, Vol. 12 Issue 10, p1 

    Background: Phosphodiesterase 4 (PDE4) inhibitors increase intracellular cyclic adenosine monophosphate (cAMP), leading to regulation of inflammatory cell functions. Roflumilast is a potent and targeted PDE4 inhibitor. The objective of this study was to evaluate the effects of roflumilast on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics